Consortial Project 3 is using whole genome sequencing to identify genetic diversity in genes known to be associated with resistance to severa malaria, within and across malaria-endemic populations.
Our primary objective is to characterise genetic diversity in genes known to be associated with malaria.
To date, this work has involved:
This project began shortly after MalariaGEN was formed in 2005, and has greatly influenced our approach to collaborative science.
MalariaGEN Consortial Projects 1-4 are overseen by a Governance Committee.
The Publications and Presentations Committee (PPC) helps ensure that publications and presentations arising from our human consortial projects meet the criteria outlined in the Joint Policy of Data Sharing, Intellectual Property and Publications.
Samples were collected from 2,217 individuals through a number of community-based studies.
Investigators involved in Consortial Project 3 include: